(Q33430547)

English

Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study.

scientific article

Statements

Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit